Marksans Pharma Dec '11 sales at Rs 31.42 crore

Published on Thu, Feb 16, 2012 at 17:07 |  Source : Moneycontrol.com

2901 Investors following Marksans Pharma. Share this News with them.
0
0
Share on Tumblr
Marksans Pharma has reported a sales turnover of Rs 31.42 crore and a net loss of Rs 60.54 crore for the quarter ended Dec '11.
For the quarter ended Dec 2010 the sales turnover was Rs 35.25 crore and net loss was Rs 2.07 crore.
Quarterly Results of Marksans Pharma-------- in Rs. Cr. --------
Dec '10Sep '11Dec '11
Sales Turnover35.2550.5231.42
Other Income------
Total Income35.2550.5231.42
Total Expenses34.6235.7488.02
Operating Profit0.6314.78-56.60
Profit On Sale Of Assets------
Profit On Sale Of Investments------
Gain/Loss On Foreign Exchange------
VRS Adjustment------
Other Extraordinary Income/Expenses------
Total Extraordinary Income/Expenses1.76----
Tax On Extraordinary Items------
Net Extra Ordinary Income/Expenses------
Gross Profit0.6314.78-56.60
Interest3.572.863.08
PBDT-1.1911.92-59.68
Depreciation0.8814.100.86
Depreciation On Revaluation Of Assets------
PBT-2.07-2.18-60.54
Tax------
Net Profit-2.07-2.18-60.54
Prior Years Income/Expenses------
Depreciation for Previous Years Written Back/ Provided------
Dividend------
Dividend Tax------
Dividend (%)------
Earnings Per Share------
Book Value------
Equity36.7836.7836.78
Reserves------
Face Value1.001.001.00
Source : Dion Global Solutions Limited

  

Trending News

Business News

2TB drives offer best value for money
Did Sebi miss any tricks in Ambani consent order? "Did Sebi miss any tricks in Ambani consent order?"

Oppn gears up to make Bharat bandh a success

On Facebook IPO Morgan Stanley Speculation Of 'Nefarious Activity' Around IPO Untrue

The latest earning numbers FIRST on CNBC-TV18
Videos

May 30 2012, 23:16

Clash of Spain and ECB worrying investors: Verstrate

- in FII View

May 30 2012, 11:18

Result corner: Ajay Bodke`s top bets from across sectors

- in MARKET OUTLOOK

Interviews

May 30 2012, 17:04 | Source: CNBC-TV18

Margins may be hit on one-off items in EBITDA: Sun Pharma  

May 30 2012, 16:32 | Source: CNBC-TV18

Essar announces Rs 175cr deal; to pay-off debts with fund  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!